Study shows tofacitinib medication can fix porousness absconds in the digestive tract Kumar Jeetendra | October 6, 2020 A team of researchers led by biomedical scientist Declan F. McCole in the University of California, Riverside, has found that the medication tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can fix permeability defects in the intestine. Study results appear in the Journal of Crohn’s and Colitis. …
Conceivable new anti-microbial created for drug-resistant pulmonary microorganism Kumar Jeetendra | December 9, 2020 Scientists from Johns Hopkins University and Medicine have developed a potential new antibiotic for a pathogen that is notoriously resistant to drugs and often lethal for people with cystic fibrosis and other lung disorders. The pathogen, called Mycobacterium abscessus, is related to some better-known bacterium that causes tuberculosis and leprosy but has recently emerged as …
New investigation shows interface between intestinal microbiota and maternal behavior Kumar Jeetendra | January 30, 2021 As scientists learn more about the microorganisms that colonize the human anatomy –collectively referred to as the microbiota–one area of extreme interest is the effect that these microbes can have on the mind. A new study headed by Salk Institute scientists has identified a strain of E. coli bacteria that, when living in the guts …
Basic dietary enhancement enhances schizophrenic traits in mice Kumar Jeetendra | April 20, 2021 After additional experiments, including visualizing the fluorescently stained dancing advantage of brain cells, researchers concluded that the nutritional supplement likely protects proteins which build neurons’ mobile skeletons. The supplement betaine was initially isolated from sugar beets and is often associated with sweetness or umami flavor. Healthy levels of betaine come from both outside food sources …